Fluphenazine路HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils

详细信息    查看全文

• 作者：Courtney O. Zlatic ; Yu Mao ; Timothy M. Ryan ; Yee-Foong Mok ; Blaine R. Roberts ; Geoffrey J. Howlett ; Michael D. W. Griffin
• 刊名：Biochemistry
• 出版年：2015
• 出版时间：June 23, 2015
• 年：2015
• 卷：54
• 期：24
• 页码：3831-3838
• 全文大小：385K
• ISSN：1520-4995

文摘

Protein misfolding and aggregation, leading to amyloid fibril formation, are characteristic of many devastating and debilitating amyloid diseases. Accordingly, there is significant interest in the mechanisms underlying amyloid fibril formation and identification of possible intervention tools. Small molecule drug compounds approved for human use or for use in phase I鈥揑II clinical trials were investigated for their effects on amyloid formation by human apolipoprotein (apo) C-II. Several of these compounds modulated the rate of amyloid formation by apoC-II. Epigallocatechin gallate (EGCG), a green tea catechin, was an effective inhibitor of apoC-II fibril formation, and the antipsychotic drug, fluphenazine路HCl, was a potent activator. Both EGCG and fluphenazine路HCl exerted concentration-dependent effects on the rate of fibril formation, bound to apoC-II fibrils with high affinity, and competitively reduced thioflavin T binding. EGCG significantly altered the size distribution of fibrils, most likely by promoting the lateral association of fibrils and subsequent formation of large aggregates. Fluphenazine路HCl did not significantly alter the size distribution of fibrils, but it may induce the formation of a small population of rod-like fibrils that differ from the characteristic ribbon-like fibrils normally observed for apoC-II. The findings of this study emphasize the effects of small molecule drugs on the kinetics of amyloid fibril formation and their roles in determining fibril structure and aggregate size.